Pathova GTM

Clinical proof doesn't close hospital deals. Commercial infrastructure does. Pathova GTM builds commercialization infrastructure for life sciences companies selling into regulated healthcare markets. If you're post-clearance and post-funding but still stuck between pilots and paid contracts, the problem isn't your technology. It's the commercialization gap. Regulatory approval proves your science works. Hospitals, health systems, and regulated buyers don't buy on clinical proof alone. They buy through: • Multi-stakeholder procurement • Complex reimbursement pathways • Long, non-linear sales cycles • Buying committees that speak different languages Most R&D-led teams were never built for this. We don't deliver strategy decks or consultant advice. We build execution-ready systems your team can actually run. What we build: - Target Account Systems ICP frameworks that identify which hospitals are positioned to buy, and qualification criteria that prevent wasted cycles. - Stakeholder Engagement Playbooks Role-specific value propositions and coalition-building frameworks for clinicians, finance, IT, procurement, and committees. - Economic Positioning & ROI Models Hospital-specific economic cases that translate outcomes into CFO language and withstand finance scrutiny. - Evidence Architecture Structured clinical, operational, financial, technical, and risk evidence, mapped to every stakeholder's decision criteria. - Sales Execution Protocols Repeatable methods to convert pilots, forecast revenue, and scale beyond founder-led selling. Not consulting. Not headcount replacement. Infrastructure your team executes. The result: shorter sales cycles, higher conversion rates, and commercial traction that matches the quality of your science.